United Health Products EBITDA Margin 2015-2024 | UEEC
United Health Products EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2021-03-31 | $0.00B | $-0.04B | 0.00% |
2020-12-31 | $0.00B | $-0.02B | 0.00% |
2020-03-31 | $0.00B | $0.00B | 0.00% |
2019-06-30 | $0.00B | $0.00B | 0.00% |
2018-12-31 | $0.00B | $0.00B | 0.00% |
2018-09-30 | $0.00B | $0.00B | 0.00% |
2018-06-30 | $0.00B | $0.00B | 0.00% |
2018-03-31 | $0.00B | $0.00B | 0.00% |
2017-12-31 | $0.00B | $0.00B | 0.00% |
2017-09-30 | $0.00B | 0 | 0.00% |
2017-06-30 | $0.00B | 0 | 0.00% |
2017-03-31 | $0.00B | 0 | 0.00% |
2016-12-31 | $0.00B | 0 | 0.00% |
2016-06-30 | $0.00B | 0 | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED PRODUCTS | $0.064B | $0.000B |
United Health Products, Inc. develop, manufactures and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and control bleeding. It serves dental and medical markets. United Health Products, Inc. is based in Henderson, Nevada. |